DCVC

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Climate tech · Jul 27, 2026

DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.

Recorded funding activity

TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$100M
1 disclosed · full round size, not this investor’s share

By stage

Series B1

By primary sector

Climate tech1

By country

United States1

Rounds

1 in this selection
Rainmaker

Rainmaker develops cloud-seeding technology and atmospheric research tools to increase freshwater supply.

$100MSeries B
Participant